Patents Assigned to Carnell Therapeutics Corporation
  • Patent number: 8529956
    Abstract: Blood-derived plastic articles prepared from compositions including blood and, in some embodiments, at least one crosslinking agent and/or at least one biological response modifier, that can be useful for biological applications such as wound repair and tissue grafts; methods of making and using the same; methods for assessing the concentration of a biological response modifier in an article; and systems for preparing blood-derived plastic articles are provided.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: September 10, 2013
    Assignees: Carnell Therapeutics Corporation, Carnegie Mellon University, Allegheny-Singer Research Institute
    Inventors: Phil G. Campbell, James E. Burgess, Lee E. Weiss, Jason Smith
  • Patent number: 8529960
    Abstract: Blood-derived plastic articles prepared from compositions including blood and, in some embodiments, at least one crosslinking agent and/or at least one biological response modifier, that can be useful for biological applications such as wound repair and tissue grafts; methods of making and using the same; methods for assessing the concentration of a biological response modifier in an article; and systems for preparing blood-derived plastic articles are provided.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: September 10, 2013
    Assignees: Carnell Therapeutics Corporation, Allegheny-Singer Research Institute, Carnegie Mellon University
    Inventors: Phil G. Campbell, James E. Burgess, Lee E. Weiss, Jason Smith